Lung Cancer Clinical Trial
Official title:
Exercise Capacity, Muscle Strength, Respiratory Characteristics, Physical Activity and Quality of Life in Patients With Lung Cancer Awaiting Surgery
To detect comparatively the extent to which physical impairments are observed in patients with lung cancer awaiting lung surgery, comparing exercise capacity, pulmonary functions, muscle strength, physical activity, dyspnea, fatigue and quality of life between the patients with lung cancer and healthy individuals was aimed in current study.
According to global cancer statistics, the most commonly diagnosing and the highest mortality
rates belong to lung cancer. As known, patients with lung cancer suffer from many
pathophysiological changes due to characteristics of the lung cancer and its cytotoxic
treatments including chemotherapy and radiotherapy. Especially, these changes commonly occur
in respiratory mechanics and gas exchange all of which resulted in pulmonary function
impairment. Moreover, excessive weight loss, anemia, protein catabolism, muscle wasting,
skeletal muscle atrophy and inhibition of muscle regeneration are observed in these patients
in course of time.
The 6-minute walk test provides valuable and valid knowledge about exercise intolerance in
diseases. As known, progressive decline in exercise capacity is commonly observed in patients
with lung cancer. The loss of muscle mass also happens not only peripheral muscle but also
respiratory muscles in patients with lung cancer. Based on the limited studies regarding
patients with lung cancer, weakness in respiratory muscles before surgery has been
demonstrated. Furthermore, these patients experience fatigue and dyspnea perceptions all of
which increase disease burden and afflict quality of life.
According to the results of a study compared the patients with lung cancer before surgery and
healthy individuals, the patients are less physically active than healthy individuals.
Moreover, at the diagnosis stage, the patients have worse quadriceps muscle strength,
nutritional status, mood and quality of life compared to others. After six months, the
patients experience decreases in physical activity, 6-minute walk test distance, and muscle
strength and worsening symptoms following chemotherapy, radiotherapy and/or surgery. On the
other hand, it could not be clearly demonstrated in the literature to the amount of
impairments of pulmonary function and respiratory muscle strength compared to healthy
individuals.
To reveal aforementioned impairments in patients with lung cancer before surgery is of
importance in terms of being helpful in both determining the protective rehabilitation
program and also reducing the disease burden and other possible factors in lung cancer.
Therefore, the aim of the current study was to investigate the differences in exercise
capacity, pulmonary functions, respiratory and peripheral muscle strength, physical activity
level, dyspnea, fatigue and quality of life between the patients with lung cancer before lung
surgery and gender and age-matched healthy individuals.
;
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT03918538 -
A Series of Study in Testing Efficacy of Pulmonary Rehabilitation Interventions in Lung Cancer Survivors
|
N/A | |
Recruiting |
NCT05078918 -
Comprehensive Care Program for Their Return to Normal Life Among Lung Cancer Survivors
|
N/A | |
Active, not recruiting |
NCT04548830 -
Safety of Lung Cryobiopsy in People With Cancer
|
Phase 2 | |
Completed |
NCT04633850 -
Implementation of Adjuvants in Intercostal Nerve Blockades for Thoracoscopic Surgery in Pulmonary Cancer Patients
|
||
Recruiting |
NCT06006390 -
CEA Targeting Chimeric Antigen Receptor T Lymphocytes (CAR-T) in the Treatment of CEA Positive Advanced Solid Tumors
|
Phase 1/Phase 2 | |
Recruiting |
NCT06037954 -
A Study of Mental Health Care in People With Cancer
|
N/A | |
Recruiting |
NCT05583916 -
Same Day Discharge for Video-Assisted Thoracoscopic Surgery (VATS) Lung Surgery
|
N/A | |
Completed |
NCT00341939 -
Retrospective Analysis of a Drug-Metabolizing Genotype in Cancer Patients and Correlation With Pharmacokinetic and Pharmacodynamics Data
|
||
Not yet recruiting |
NCT06376253 -
A Phase I Study of [177Lu]Lu-EVS459 in Patients With Ovarian and Lung Cancers
|
Phase 1 | |
Recruiting |
NCT05898594 -
Lung Cancer Screening in High-risk Black Women
|
N/A | |
Active, not recruiting |
NCT05060432 -
Study of EOS-448 With Standard of Care and/or Investigational Therapies in Participants With Advanced Solid Tumors
|
Phase 1/Phase 2 | |
Active, not recruiting |
NCT03575793 -
A Phase I/II Study of Nivolumab, Ipilimumab and Plinabulin in Patients With Recurrent Small Cell Lung Cancer
|
Phase 1/Phase 2 | |
Active, not recruiting |
NCT03667716 -
COM701 (an Inhibitor of PVRIG) in Subjects With Advanced Solid Tumors.
|
Phase 1 | |
Terminated |
NCT01624090 -
Mithramycin for Lung, Esophagus, and Other Chest Cancers
|
Phase 2 | |
Terminated |
NCT03275688 -
NanoSpectrometer Biomarker Discovery and Confirmation Study
|
||
Not yet recruiting |
NCT04931420 -
Study Comparing Standard of Care Chemotherapy With/ Without Sequential Cytoreductive Surgery for Patients With Metastatic Foregut Cancer and Undetectable Circulating Tumor-Deoxyribose Nucleic Acid Levels
|
Phase 2 | |
Recruiting |
NCT06010862 -
Clinical Study of CEA-targeted CAR-T Therapy for CEA-positive Advanced/Metastatic Malignant Solid Tumors
|
Phase 1 | |
Recruiting |
NCT06052449 -
Assessing Social Determinants of Health to Increase Cancer Screening
|
N/A | |
Not yet recruiting |
NCT06017271 -
Predictive Value of Epicardial Adipose Tissue for Pulmonary Embolism and Death in Patients With Lung Cancer
|
||
Recruiting |
NCT05787522 -
Efficacy and Safety of AI-assisted Radiotherapy Contouring Software for Thoracic Organs at Risk
|